The Ligandable Human Proteome

Tyrosine-protein kinase BTK

Index	Ligand Name	Structure	PDB code	ligand desolvation
1	7gb	BTK1 BINDS COVALENTLY TO HY-15771 ONO-4059	5p9m	92.58
2	4rv	Crystal Structure of Bruton's Tyrosine Kinase in complex with a substituted Cinnoline	4zlz	91.96
3	jvp	Crystal structure of mouse BTK kinase domain in complex with compound 9a	6mny	91.26
4	9b1	Bruton's tyrosine kinase (BTK) with compound G-744	5vgo	90.27
5	b43	The 1.6 A crystal structure of human bruton's tyrosine kinase bound to a pyrrolopyrimidine-containing compound	3gen	89.07
6	ba0	Co-crystal structure of BTK kinase domain with Zanubrutinib	6j6m	86.66
7	1e8	BTK1 SOAKED WITH IBRUTINIB-Rev	5p9i	86.65
8	83p	Discovery of a potent BTK inhibitor with a novel binding mode using parallel selections with a DNA-encoded chemical library	5u9d	86.16
9	l9s	Brutons tyrosine kinase in complex with compound 50.	6nzm	85.88
10	hra	Crystal structure of ARQ 531 in complex with the kinase domain of BTK	6e4f	85.42
11	5wf	BTK kinase domain with inhibitor 1	5fbn	85.34
12	gj7	CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH COVALENT INHIBITOR	6di5	85.06
13	8e8	BTK1 COCRYSTALLIZED WITH IBRUTINIB	5p9j	85.03
14	04l	Crystal structure of BTK kinase domain complexed with 2-Methyl-5-[(E)-(3-phenyl-acryloyl)amino]-N-(2-phenyl-3H-imidazo[4,5-b]pyridin-6-yl)-benzamide	3pj3	84.93
15	mzj	Structure of human Bruton's Tyrosine Kinase in complex with Evobrutinib	6omu	84.86
16	gja	CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH FRAGMENT LIGAND	6di3	84.63
17	khd	Discovery of affinity-based probes for Btk occupancy assay	6n9p	84.63
18	2v2	Crystal structure of BTK kinase domain complexed with 1-[5-[3-(7-tert-butyl-4-oxo-quinazolin-3-yl)-2-methyl-phenyl]-1-methyl-2-oxo-3-pyridyl]-3-methyl-urea	4otq	84.62
19	4c9	Bruton's tyrosine kinase in complex with a t-butyl cyanoacrylamide inhibitor	4yhf	82.75
20	5wh	BTK-inhibitor co-structure	5fbo	82.51
21	6xl	Bruton's tyrosine kinase (BTK) with pyridazinone compound 9	5kup	82.14
22	gjd	CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH COVALENT FRAGMENT LIGAND	6di1	81.86
23	gyl	The structure of human BTK kinase domain in complex with a covalent inhibitor	5xyz	81.76
24	ltj	BTK In Complex With Inhibitor	6o8i	80.73
25	dxm	BTK complex with compound 12	6bkw	80.58
26	1n1	Crystal structure of bruton's tyrosine kinase mutant V555R in complex with dasatinib	3oct	79.71
27	klp	BTK in complex with inhibitor N-(3-{[(2,6-dimethylphenyl)methyl]amino}-7-methoxyindeno[1,2-c]pyrazol-6-yl)methanesulfonamide	6nfi	79.19
28	gjg	CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH FRAGMENT LIGAND	6di0	79.15
29	dy4	BTK complex with compound 13	6bln	78.38
30	2vl	BTK IN COMPLEX WITH GDC-0834	5p9f	76.19
31	dvj	BTK complex with compound 10	6bke	75.71
32	gmw	CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 12-(6-tert-butyl-8-fluoro-1-oxo-phthalazin-2-yl)-9-hydroxy-6-methyl-4-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-azatricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,11,13-pentaen-5-one	6hrt	75.43
33	2p5	Crystal structure of Bruton agammaglobulinemia tyrosine kinase complexed with BMS-809959 aka 4-tert-butyl-n-[2-me thyl-3-(6-{[4-(morpholine-4-carbonyl)phenyl]amino}-9h- purin-2-yl)phenyl]benzamide	4nwm	75.28
34	746	Crystal structure of the PH-TH-kinase construct of Bruton's tyrosine kinase (Btk)	4y93	75.04
35	dvd	BTK complex with compound 11	6bkh	74.51
36	3ou	Crystal structure of BTK kinase domain complexed with 6-(dimethylamino)-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]-3,4-dihydroisoquinolin-1-one	4rfy	74.39
37	585	Crystal structure of BTK kinase domain complexed with R406	3piy	74.38
38	3ov	Crystal structure of BTK kinase domain complexed with 6-(dimethylamino)-8-fluoro-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]isoquinolin-1-one	4rfz	74.36
39	2vl	Crystal structure of the kinase domain of Bruton's Tyrosine kinase with GDC0834	4otf	74.27
40	481	Crystal structure of BTK kinase domain complexed with 4-tert-Butyl-N-(3-{8-[4-(4-methyl-piperazine-1-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-benzamide	4ot5	74.23
41	3yo	Bruton's tyrosine kinase (BTK) with pyridazinone compound 23	4rx5	74.07
42	1n1	Structures of human Bruton's tyrosine kinase in active and inactive conformations suggests a mechanism of activation for TEC family kinases.	3k54	73.67
43	3p0	Crystal structure of BTK kinase domain complexed with 2-[8-fluoro-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(4-methylpiperazin-1-yl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]-1-oxo-3,4-dihydroisoquinolin-6-yl]-2-methyl-propanenitrile	4rg0	72.96
44	bxm	CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI2815	6aub	72.64
45	746	Crystal structure of the kinase domain of Bruton's tyrosine kinase with mutations in the activation loop	4y95	72.59
46	dtj	BTK complex with compound 7	6bik	72.49
47	9m3	Crystal structure of bruton's tyrosine kinase in complex with inhibitor 2e	5zz4	72.44
48	7g6	Structure of BTK with RN486	5p9g	72.41
49	bnb	Crystal structure of BTK kinase domain complexed with N-[2-methyl-3-[4-methyl-6-[4-(4-methylpiperazine-1-carbonyl)anilino]-5-oxo-pyrazin-2-yl]phenyl]-4-(1-piperidyl)benzamide	6ep9	72.4
50	746	Crystal structure of bruton's tyrosine kinase in complex with inhibitor CGI1746	3ocs	72.37
51	2v3	Crystal structure of BTK kinase domain complexed with 6-cyclopropyl-2-[3-[5-[[5-(4-ethylpiperazin-1-yl)-2-pyridyl]amino]-1-methyl-6-oxo-3-pyridyl]-2-(hydroxymethyl)phenyl]-8-fluoro-isoquinolin-1-one	4otr	72.26
52	03c	Crystal structure of BTK kinase domain complexed with (5-Amino-1-o-tolyl-1H-pyrazol-4-yl)-[3-(1-methanesulfonyl-piperidin-4-yl)-phenyl]-methanone	3piz	71.49
53	5we	BTK kinase domain with inhibitor 1	5fbn	71.23
54	bxj	CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI2625	6aua	70.81
55	7g7	BTK1 COCRYSTALLIZED WITH RN983	5p9h	70.78
56	6mv	CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO -3,4-DIHYDROQUINAZOLIN-3-YL)PHENYL]-7-(2-HYDROXYPROPAN-2-Y L)-9H-CARBAZOLE-1-CARBOXAMIDE	5jrs	70.71
57	9aj	Bruton's tyrosine kinase (BTK) with GDC-0853	5vfi	69.83
58	l0z	BTK in complex with an inhibitor	6s90	69.03
59	lhl	Crystal structure of BTK kinase domain complexed with 3-(2,6-Dichloro-phenyl)-7-[4-(2-diethylamino-ethoxy)-phenylamino]-1-methyl-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one	3pj1	68.76
60	73t	Crystal structure of Bruton agammabulinemia tyrosine kinase complexed with BMS-986142 aka (2s)-6-fluoro-5-[3-(8-fluoro-1-methyl-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)-2-methylphenyl]-2-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1h-carbazole-8-carboxamide	5t18	67.47
61	4us	Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with BMS-824171 AKA 6-[(3R)-3-(4-tert-bu tylbenzamido)piperidin-1-yl]-2-{[4-(morpholine-4-carbonyl) phenyl]amino}pyridine-3-carboxamide	5bq0	67.17
62	04k	Crystal structure of BTK kinase domain complexed with 2-[4-(2-Diethylamino-ethoxy)-phenylamino]-6-(4-fluoro-phenoxy)-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one	3pj2	66.06
63	klm	BTK in complex with inhibitor 8-(2,3-dihydro-1H-inden-5-yl)-2-({4-[(2S)-3-(dimethylamino)-2-hydroxypropoxy]phenyl}amino)-5,8-dihydropteridine-6,7-dione	6nfh	65.85
64	027	Crystal structure of BTK kinase domain complexed with 2-Isopropyl-7-(4-methyl-piperazin-1-yl)-4-(5-methyl-2H-pyrazol-3-ylamino)-2H-phthalazin-1-one	3pix	63.5
65	7g9	BTK1 IN COMPLEX WITH CC 292	5p9l	62.94
66	7g8	CRYSTAL STRUCTURE OF BTK with CNX 774	5p9k	58.69
67	gjj	CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH COVALENT INHIBITOR	6di9	58.25
68	4uq	Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with BMS-824171 AKA 6-[(3R)-3-(4-tert-bu tylbenzamido)piperidin-1-yl]-2-{[4-(morpholine-4-carbonyl) phenyl]amino}pyridine-3-carboxamide	5bpy	57.04
69	2v1	Crystal structure of BTK kinase domain complexed with 4-Methanesulfonyl-N-(3-{8-[4-(morpholine-4-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-benzamide	4ot6	52.23